Coeptis Total Liab vs Capital Lease Obligations Analysis
| COEPW Stock | USD 0.02 0 19.50% |
Coeptis Therapeutics financial indicator trend analysis is way more than just evaluating Coeptis Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Coeptis Therapeutics is a good investment. Please check the relationship between Coeptis Therapeutics Total Liab and its Capital Lease Obligations accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Coeptis Therapeutics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For more information on how to buy Coeptis Stock please use our How to Invest in Coeptis Therapeutics guide.
Total Liab vs Capital Lease Obligations
Total Liab vs Capital Lease Obligations Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Coeptis Therapeutics Total Liab account and Capital Lease Obligations. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Coeptis Therapeutics' Total Liab and Capital Lease Obligations is -0.06. Overlapping area represents the amount of variation of Total Liab that can explain the historical movement of Capital Lease Obligations in the same time period over historical financial statements of Coeptis Therapeutics Holdings, assuming nothing else is changed. The correlation between historical values of Coeptis Therapeutics' Total Liab and Capital Lease Obligations is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Liab of Coeptis Therapeutics Holdings are associated (or correlated) with its Capital Lease Obligations. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Lease Obligations has no effect on the direction of Total Liab i.e., Coeptis Therapeutics' Total Liab and Capital Lease Obligations go up and down completely randomly.
Correlation Coefficient | -0.06 |
| Relationship Direction | Negative |
| Relationship Strength | Insignificant |
Total Liab
The total amount of all liabilities that a company has, including both short-term and long-term liabilities.Capital Lease Obligations
Coeptis Therapeutics capital lease obligations are the amount due for long-term lease agreements that are nearly equivalent to Coeptis Therapeutics asset purchases. For example, Coeptis Therapeutics can use a capital lease to finance the purchase of an asset without ever buying it. A capital lease gives companies such as Coeptis Therapeutics control over an asset for a big portion of its life. The total obligations of a company under capital leases, which are lease agreements that transfer substantially all risks and rewards of ownership to the lessee.Most indicators from Coeptis Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Coeptis Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Coeptis Therapeutics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For more information on how to buy Coeptis Stock please use our How to Invest in Coeptis Therapeutics guide.Issuance Of Capital Stock is likely to climb to about 5 M in 2024, whereas Selling General Administrative is likely to drop slightly above 24.3 M in 2024.
| 2021 | 2022 | 2023 | 2024 (projected) | Other Operating Expenses | 14.1M | 34.2M | 39.3M | 41.3M | Depreciation And Amortization | 447.4K | 1.0M | 901.2K | 719.4K |
Coeptis Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Coeptis Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Coeptis Stock Analysis
When running Coeptis Therapeutics' price analysis, check to measure Coeptis Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coeptis Therapeutics is operating at the current time. Most of Coeptis Therapeutics' value examination focuses on studying past and present price action to predict the probability of Coeptis Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coeptis Therapeutics' price. Additionally, you may evaluate how the addition of Coeptis Therapeutics to your portfolios can decrease your overall portfolio volatility.